Serina Therapeutics, Inc.
SER· NYSE
Released Nov 14, 2023, after the close
10-Q filed Nov 14, 2023, 45 days after period end · 0001493152-23-041126
| Metric | Q3 2023 | Q3 2022 | Q3 2021 | Q3 2020 |
|---|---|---|---|---|
| Revenue | $29.00K | $9.00K | $24.00K | $69.00K |
| Net Income | $1.75M | -$2.44M | -$1.96M | -$2.54M |
| EPS Diluted |
Serina Therapeutics, Inc. · CIK 1708599 · Engraved from SEC EDGAR
| $0.23 |
| -$0.06 |
| -$0.05 |
| -$0.07 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.